Abiopharma

Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference

Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment

VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement

Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date

Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis

Beyond Air® Signs New International LungFitPH® Distribution Agreements, Most Notably in Germany and Brazil

Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates

NorthStrive Biosciences Advances to Phase III of AI-Driven Drug Discovery Program Toward Validation of Multiple Potential Drug Compounds & Discoveries

Danaher Schedules Fourth Quarter 2025 Earnings Conference Call

Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package